Literature DB >> 19806495

Challenges in the evaluation, consent, ethics and history of early clinical trials - Implications of the Tuskegee 'trial' for safer and more ethical clinical trials.

Pedro R Lowenstein1, Elijah D Lowenstein, Maria G Castro.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19806495      PMCID： PMC2864135     

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN： 1464-8431


× No keyword cloud information.
  20 in total

1.  Untreated syphilis in the male negro; background and current status of patients in the Tuskegee study.

Authors:  S H SCHUMAN; S OLANSKY; E RIVERS; C A SMITH; D S RAMBO
Journal:  J Chronic Dis       Date:  1955-11

2.  Twenty years of followup experience in a long-range medical study.

Authors:  E RIVERS; S H SCHUMAN; L SIMPSON; S OLANSKY
Journal:  Public Health Rep       Date:  1953-04       Impact factor: 2.792

3.  Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers.

Authors:  Scott Y H Kim; Samuel Frank; Robert Holloway; Carol Zimmerman; Renee Wilson; Karl Kieburtz
Journal:  Arch Neurol       Date:  2005-09

4.  Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study.

Authors:  J H Fetting; L A Siminoff; S Piantadosi; M D Abeloff; D J Damron; A M Sarsfield
Journal:  J Clin Oncol       Date:  1990-09       Impact factor: 44.544

Review 5.  Practical Bayesian adaptive randomisation in clinical trials.

Authors:  Peter F Thall; J Kyle Wathen
Journal:  Eur J Cancer       Date:  2007-02-16       Impact factor: 9.162

Review 6.  Assessing and communicating the risks and benefits of gene transfer clinical trials.

Authors:  Scott Y H Kim
Journal:  Curr Opin Mol Ther       Date:  2006-10

Review 7.  Bayesian clinical trials.

Authors:  Donald A Berry
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

8.  Progress toward a more ethical method for clinical trials.

Authors:  J B Kadane
Journal:  J Med Philos       Date:  1986-11

9.  Utility-based optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trials.

Authors:  Nadine Houede; Peter F Thall; Hoang Nguyen; Xavier Paoletti; Andrew Kramar
Journal:  Biometrics       Date:  2009-08-10       Impact factor: 2.571

10.  Human guinea pigs: medical experimentation before World War II. [Review of: Lederer SE. Subjected to science: human experimentation in America before the Second World War. Johns Hopkins University Press, 1995].

Authors:  D Rosner
Journal:  Rev Am Hist       Date:  1996-12
View more
  3 in total

1.  Risk in clinical research: size matters!

Authors:  Pedro R Lowenstein
Journal:  Mol Ther       Date:  2009-11       Impact factor: 11.454

Review 2.  Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments.

Authors:  Mahmoud S Alghamri; Brandon L McClellan; Carson S Hartlage; Santiago Haase; Syed Mohd Faisal; Rohit Thalla; Ali Dabaja; Kaushik Banerjee; Stephen V Carney; Anzar A Mujeeb; Michael R Olin; James J Moon; Anna Schwendeman; Pedro R Lowenstein; Maria G Castro
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.988

Review 3.  Current Approaches for Glioma Gene Therapy and Virotherapy.

Authors:  Kaushik Banerjee; Felipe J Núñez; Santiago Haase; Brandon L McClellan; Syed M Faisal; Stephen V Carney; Jin Yu; Mahmoud S Alghamri; Antonela S Asad; Alejandro J Nicola Candia; Maria Luisa Varela; Marianela Candolfi; Pedro R Lowenstein; Maria G Castro
Journal:  Front Mol Neurosci       Date:  2021-03-11       Impact factor: 5.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.